<DOC>
	<DOC>NCT01740362</DOC>
	<brief_summary>A study to evaluate the pharmacokinetics of CP-690,550 in subjects with mild, moderate or severe renal impairment, who do not require hemodialysis, compared to healthy controls.</brief_summary>
	<brief_title>Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects with normal renal function: Subjects must be healthy with estimated creatinine clearance &gt;80 mL/min Subjects with renal impairment: Subjects should be in good general health commensurate with the population with chronic kidney disease Kidney transplant patients Subjects with any condition possibly affecting drug absorption Subjects with malignancies with the exception of adequately treated basal cell carcinoma of the skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>renal impairment</keyword>
</DOC>